Background & Aims: In patients with nonalcoholic fatty liver disease (NAFLD), insulin resistance (IR) associates with fibrosis progression independently of hepatic inflammation, but the mechanisms are still unclear. Methods : We modeled the independent contribution of inflammation (steatohepatitis: NASH) by exploiting the methionine-choline deficient (MCD) diet, and that of IR by insulin receptor haploinsufficiency (InsR+/-), in the pathogenesis of liver fibrosis in C57Bl/6 mice. We confirmed study findings in 96 patients with NAFLD. Results: InsR+/- enhanced hepatic fat content and impaired hepatic insulin signaling leading to Forkhead box protein O1 (FoxO1) accumulation in MCD-fed mice. Remarkably, despite reduced inflammation and hampered trans-differentiation of hepatic stellate cells (HSCs), InsR+/- promoted hepatic fibrosis accumulation, which correlated with induction of the Lysyl-oxidase like-2 (Loxl2), involved in matrix stabilization. Loxl2 upregulation was not a cell-autonomous property of insulin resistant HSCs, but was dependent on microparticles released specifically by insulin resistant hepatocytes exposed to fatty acids. The mechanism entailed FoxO1 upregulation, as FoxO1 silencing normalized Loxl2 expression reversing fibrosis in InsR+/-MCD-fed mice. Loxl2 upregulation was similarly detected during IR induced by obesity, but not by lipogenic stimuli (fructose feeding). Most importantly, LOXL2 upregulation was observed in NAFLD patients with type 2 diabetes, and LOXL2 hepatic and circulating levels correlated with histological fibrosis progression. Conclusions: IR favors fibrosis deposition independently of the classic "inflammation - HSC trans-differentiation" pathway. The mechanism entails a cross-talk between enhanced lipotoxicity in insulin resistant hepatocytes and Loxl2 production by HSCs, which was confirmed in patients with diabetes, thereby facilitating extracellular matrix stabilization.
Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in nonalcoholic fatty liver disease / P. Dongiovanni, M. Meroni, G.A. Baselli, G.A. Bassani, R. Rametta, A. Pietrelli, M. Maggioni, F. Facciotti, V. Trunzo, S. Badiali, S. Fargion, S. Gatti, L.V.C. Valenti. - In: CLINICAL SCIENCE. - ISSN 0143-5221. - 131:12(2017 May 03), pp. 1301-1315.
|Titolo:||Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in nonalcoholic fatty liver disease|
DONGIOVANNI, PAOLA (Primo)
MERONI, MARICA (Secondo)
VALENTI, LUCA VITTORIO CARLO (Ultimo)
|Parole Chiave:||Experimental model; FoxO1; Nash; diabetes; extracellular matrix|
|Settore Scientifico Disciplinare:||Settore MED/09 - Medicina Interna|
|Data di pubblicazione:||3-mag-2017|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1042/CS20170175|
|Appare nelle tipologie:||01 - Articolo su periodico|